Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: A retrospective follow up study

被引:1
|
作者
Abera, Netsanet Melkamu [1 ]
Alemu, Tewodros Getaneh [2 ,3 ]
Agegnehu, Chilot Desta [3 ,4 ]
机构
[1] Dire Dawa Univ, Dept Nursing, Coll Med & Hlth Sci, Dire Dawa, Ethiopia
[2] Univ Gondar, Dept Pediat & Child Hlth Nursing, Sch Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia
[3] Univ Gondar, Comprehens Specialized Hosp, Gondar, Ethiopia
[4] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Gondar, Ethiopia
来源
PLOS ONE | 2023年 / 18卷 / 11期
关键词
DETERMINANTS;
D O I
10.1371/journal.pone.0289095
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Despite gains made from improved antiretroviral therapy coverage in resource limited countries, the occurrence of first line drug resistance remains a priority agenda. To reduce the emergence of resistant viruses, HIV viral load monitoring plays a critical role. However, many resource limited countries have difficulty of monitoring viral load due to economic constraints.There is also limited study regarding viral failure in developing countries. Therefore, this study aimed to assess the incidence and predictors of virological failure among HIV-infected children and adolescents on first-line ART Ethiopia, 2021. Methods Institution based retrospective follow-up study was employed on 492 children and adolescents. Data were collected by trained nurses who have experience working in ART clinics. Data were entered using Epi-data version 4.6 and exported to Stata version 14 for analysis. The proportional hazard assumption was checked, and the Weibull regression was fitted. Cox-Snell residual was used to test the goodness of fit, and the appropriate model was selected by AIC. Finally, an AHR with a 95% CI was computed, and variables with a P-value < 0.05 in the multivariable analysis were taken as significant predictors of virological failure. Results The overall incidence rate of virological failure was 4.2, (95% CI: 3.41, 5.22) per 1000 person-months of observation with 20,169 person-months follow-up time. In multivariable analysis living in rural area (AHR = 1.97, 95% CI: 1.15-3.36), poor adherence (AHR = 2.20, 95% CI: 1.24-3.91), lower CD4 Count <200 cells/mm3 (AHR = 2.57, 95% CI: 1.27-5.18) and 201-350 cells/mm3 (AHR = 2.44, 95% CI: 1.28-4.67) respectively, and recent OI (AHR = 4.60, 95% CI: 2.38-8.90) are significantly associated with virological failure. Conclusion The incidence rate of virological failure was high. Living in a rural, poor adherence, lower CD4 count, and recent opportunistic infection were independent risk factors associated with virological failure. Hence, it is better to give priority to strengthening the focused evaluation of important variables and managing accordingly.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study
    Agegnehu, Chilot Desta
    Merid, Mehari Woldemariam
    Yenit, Melaku Kindie
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [2] Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study
    Chilot Desta Agegnehu
    Mehari Woldemariam Merid
    Melaku Kindie Yenit
    BMC Infectious Diseases, 20
  • [3] Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study
    Yihun, Birtukan Aklog
    Kibret, Getiye Dejenu
    Leshargie, Cheru Tesema
    PLOS ONE, 2019, 14 (05):
  • [4] Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study
    Musiime-Mwase, Fiona
    Nakanjako, Damalie
    Kanywa, Jacqueline Balungi
    Nasuuna, Esther M.
    Naitala, Ronald
    Oceng, Ronald
    Sewankambo, Nelson
    Elyanu, Peter
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [5] Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study
    Yassin, Seid
    Gebretekle, Gebremedhin Beedemariam
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (01):
  • [6] Determinants of Virological Failure Among HIV-Infected Children on First-Line Antiretroviral Therapy in West Gojjam Zone, Amhara Region, Ethiopia
    Shumetie, Awoke
    Moges, Nurilign Abebe
    Teshome, Muluken
    Gedif, Getnet
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2021, 13 : 1035 - 1044
  • [7] Incidence and predictors of treatment failure among children with HIV on first-line antiretroviral therapy in Wolaita zone, Southern Ethiopia: A multicenter retrospective cohort study
    Mena, Zufan Berhanu
    Wolka, Eskinder
    Dana, Tadele
    Asmare, Getachew
    Mena, Muluken Berhanu
    Lerango, Temesgen Leka
    HELIYON, 2023, 9 (10)
  • [8] Incidence and predictors of loss to follow-up among adult HIV-infected patients taking antiretroviral therapy at North Shewa zone public Hospitals, Northeast Ethiopia: A retrospective follow-up study
    Shiferaw, Wondimeneh Shibabaw
    Belete, Abebe Muche
    Adela, Alemu
    Getnet, Mekasha
    Aynalem, Yared Asmare
    AFRICAN HEALTH SCIENCES, 2022, 22 (02) : 12 - 26
  • [9] Predictors of Anemia Among Adult HIV Positive Patients on First-Line Antiretroviral Therapy in Northwest Ethiopia: A Retrospective Follow-Up Study
    Agegnehu, Chilot Desta
    Merid, Mehari Woldemariam
    Yenit, Melaku Kindie
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2021, 13 : 455 - 466
  • [10] Determinants of Virological Failure Among Patients on First-line Antiretroviral Therapy in Central Oromia, Ethiopia: A Case-Control Study
    Abdullahi, Ilili Jemal
    Deybasso, Haji Aman
    Adlo, Abebe Megerso
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 931 - 939